FA
NVRO

Friess Associates’s NEVRO CORP. NVRO Stock Holding History

Friess Associates’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-36,792
Closed -$3.45M – 136
2017
Q1 		$3.45M Sell
36,792
-3,508
-9% -$318K 0.32% 77
2016
Q4 		$2.93M Buy
40,300
+33,600
+501% +$2.88M 0.29% 80
2016
Q3 		$699K Buy
+6,700
New +$605K 0.07% 99

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Friess Associates's NVRO Position: Q2 2017 in Review

Friess Associates sold out of NEVRO CORP. (NVRO) in Q2 2017, closing a stake of 36,792 shares — an estimated $3.45M sold.

Friess Associates first reported a position in NVRO in Q3 2016 and held it in 3 quarters. The position peaked at $3.45M in Q1 2017. 201 funds tracked by Wall St. Rank hold NVRO as of Q2 2017.

  • Friess Associates reported no remaining NEVRO CORP. position as of Q2 2017 after selling out during the quarter.
  • Friess Associates sold 36,792 NEVRO CORP. shares in Q2 2017, an estimated $3.45M.
  • Friess Associates first reported a position in NEVRO CORP. in Q3 2016 and held it in 3 quarters.
  • Friess Associates's NEVRO CORP. position peaked at $3.45M in Q1 2017.
  • 201 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2017.

Based on Friess Associates's 13F filing for Q2 2017, filed 14 Aug 2017.